Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02869646 · ClinicalTrials.gov registry record · NA

Acupuncture for PTSD

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
92
Enrollment target

NCT02869646: Completed NA study, sponsored by VA Office of Research and Development.

NCT02869646 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02869646, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
92 participants
Enrollment target

Study Summary

Current treatments for Veterans with PTSD include medications and therapy where the patient talks about traumatic events in order to desensitize to them. While these treatments work for many, a large minority of Veterans do not want medications or exposure therapy. The investigators developed an acupuncture (ACU) treatment for PTSD in order to broaden treatment options. The investigators' first study showed that it helped most people. However, the investigators need better scientific evidence that it works by comparing ACU to a placebo, such as "sham" acupuncture (fewer needles in non-important sites) and determining if ACU alters abnormal physiology in PTSD. In this study 90 Veterans will be randomly assigned (like a coin flip) to receive either ACU or sham. The investigators expect to find that the ACU treated patients have more improvement in PTSD and in physiology (less startle reaction - assessed non-invasively using skin sensors) than the patients in the sham group. This study will provide information to support the use of acupuncture for PTSD at the VA, which will expand treatment options.

Interventions

  • PROCEDURE Procedure: Acupuncture
  • PROCEDURE Procedure: Sham acupuncture

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2018-04-05
Est. Completion 2022-12-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02869646

The ClinicalTrials.gov registry entry for NCT02869646 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Procedure: Acupuncture is the first listed.

NCT02869646 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02869646 about?

NCT02869646 is a clinical study titled "Acupuncture for PTSD". Current treatments for Veterans with PTSD include medications and therapy where the patient talks about traumatic events in order to desensitize to them. While these treatments work for many, a large minority of Veterans do not want medications or exposure therapy. The investigators developed an acu...

What is the current status of trial NCT02869646?

This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2018-04-05. Estimated completion is 2022-12-30.

What interventions are being tested in trial NCT02869646?

The interventions under investigation include: Procedure: Acupuncture (PROCEDURE), Procedure: Sham acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT02869646?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.